Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 4:2014:310542.
doi: 10.1155/2014/310542. eCollection 2014.

Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center

Marisa D Santos  1 , Cristina Silva  1 , Anabela Rocha  1 , Eduarda Matos  2 , Carlos Nogueira  1 , Carlos Lopes  3
Affiliations

Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center

Marisa D Santos et al. ISRN Surg. .

Abstract

Goal. To evaluate the prognostic value of Mandard and Dworak grading systems regarding neoadjuvant chemoradiotherapy (CRT) response on rectal cancer. Materials and Methods. We queried our center's database for patients with colo rectal cancer with locally advanced rectal cancer (LARC) who received neoadjuvant CRT followed by total mesorectum excision (TME) between 2003 and 2011. After excluding 18 patients from the initial query the remaining 139 were reassessed for disease recurrence and survival; the specimens' slides were reviewed and classified according to two tumor regression grading (TRG) systems: Mandard and Dworak. Based on these TRG scores, two patient groups were created: patients with good response versus patients with bad response (Mandard TRG1+2 versus Mandard TRG3+4+5 and Dworak TRG4+3 versus Dworak TRG2+1+0). Overall survival (OS), disease-free survival (DFS), and disease recurrence were then evaluated. Results. Mean age was 64.2 years and median follow up was 56 months. No significant survival difference was found when comparing patients with Dworak TRG 4+3 versus Dworak TRG2+1+0 (P = 0.10). Mandard TRG1+2 presented with significantly better OS and DFS than Mandard TRG3+4+5 (OS P = 0.013; DFS P = 0.007). Conclusions. Mandard system provides higher accuracy over Dworak system in predicting rectal cancer prognosis when neoadjuvant CRT is applied for tumor regression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mandard system.
Figure 2
Figure 2
Dworak system.
Figure 3
Figure 3
Five-year overall survival, comparison of the two groups Mandard.
Figure 4
Figure 4
Five-year disease-free survival, comparison of the two groups Mandard.
Figure 5
Figure 5
Five-year overall survival, comparison of the two groups Dworak.
Figure 6
Figure 6
Five-year disease-free survival, comparison of the two groups Dworak.
See this image and copyright information in PMC

References

    1. den Dulk M, Krijnen P, Marijnen CAM, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. European Journal of Cancer. 2008;44(12):1710–1716. - PubMed
    1. MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. The Lancet. 1993;341(8843):457–460. - PubMed
    1. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. The Lancet Oncology. 2011;12(6):575–582. - PubMed
    1. Wheeler JMD, Dodds E, Warren BF, et al. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Diseases of the Colon and Rectum. 2004;47(12):2025–2031. - PubMed
    1. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. The Lancet Oncology. 2010;11(9):835–844. - PubMed

LinkOut - more resources